Emergent Biosolutions Earnings Estimate

EBS
 Stock
  

USD 29.72  0.83  2.72%   

Many public companies, such as Emergent Biosolutions, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Emergent Biosolutions' earnings estimates, investors can diagnose different trends across Emergent Biosolutions' analyst sentiment over time as well as compare current estimates against different timeframes.
Emergent Biosolutions is projected to generate 5.41 in earnings per share on the 31st of December 2021. Emergent Biosolutions earnings estimates module stress-tests analyst consensus about projected Emergent Biosolutions EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Continue to Investing Opportunities.
  
As of 08/09/2022, Profit Margin is likely to grow to 0.13, while Gross Profit is likely to drop slightly above 825.7 M.

Emergent Biosolutions Earnings Estimation Breakdown

Calculation of earning per share of Emergent Biosolutions is based on official Zacks consensus of 3 analysts regarding Emergent Biosolutions future annual earnings. Given the historical accuracy of 72.84%, the future earnings per share of Emergent Biosolutions is estimated to be 5.41 with the lowest and highest values of 4.69 and 6.28, respectively. Please note that this consensus of annual earnings estimates for Emergent Biosolutions is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS 4.18
4.69
Lowest
Expected EPS 5.41
6.28
Highest

Emergent Biosolutions Earnings Projection Consensus

Suppose the current estimates of Emergent Biosolutions' value are higher than the current market price of the Emergent Biosolutions stock. In this case, investors may conclude that Emergent Biosolutions is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Emergent Biosolutions' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

3

72.84%

4.18

5.41

Emergent Biosolutions Earnings History

Earnings estimate consensus by Emergent Biosolutions analysts from Wall Street is used by the market to judge Emergent Biosolutions' stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Emergent Biosolutions' upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Emergent Biosolutions Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

(30.5 Million)

As of 08/09/2022, Accumulated Retained Earnings Deficit is likely to grow to about 1 B. Also, Earning Before Interest and Taxes EBIT is likely to grow to about 376.4 M As of 08/09/2022, Weighted Average Shares Diluted is likely to grow to about 55.5 M, while Weighted Average Shares is likely to drop slightly above 53.1 M.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Emergent Biosolutions' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Emergent Biosolutions in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
25.1029.6734.24
Details
Intrinsic
Valuation
LowReal ValueHigh
26.7536.7441.31
Details
Naive
Forecast
LowNext ValueHigh
25.8230.3934.96
Details
6 Analysts
Consensus
LowTarget PriceHigh
50.0062.5075.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Emergent Biosolutions. Your research has to be compared to or analyzed against Emergent Biosolutions' peers to derive any actionable benefits. When done correctly, Emergent Biosolutions' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Emergent Biosolutions.
Note that many institutional investors and large investment bankers can move markets due to the volume of Emergent assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Emergent Biosolutions. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Emergent stock price in the short term.

Emergent Biosolutions Earnings per Share Projection vs Actual

Actual Earning per Share of Emergent Biosolutions refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Emergent Biosolutions predict the company's earnings will be in the future. The higher the earnings per share of Emergent Biosolutions, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Emergent Biosolutions Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Emergent Biosolutions, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Emergent Biosolutions should always be considered in relation to other companies to make a more educated investment decision.

Emergent Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Emergent Biosolutions' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-01
2022-06-300.38-0.86-1.24326 
2022-04-28
2022-03-310.130.180.0538 
2022-02-24
2021-12-314.274.50.23
2021-11-04
2021-09-302.35-0.36-2.71115 
2021-07-29
2021-06-301.540.33-1.2178 
2021-04-29
2021-03-311.121.530.4136 
2021-02-18
2020-12-313.193.670.4815 
2020-11-06
2020-09-302.122.190.07
2020-07-30
2020-06-300.681.981.3191 
2020-04-30
2020-03-310.010.010
2020-02-20
2019-12-311.731.57-0.16
2019-11-06
2019-09-300.91.210.3134 
2019-08-01
2019-06-300.170.12-0.0529 
2019-05-02
2019-03-310.09-0.13-0.22244 
2019-02-21
2018-12-310.650.750.115 
2018-11-01
2018-09-300.580.55-0.03
2018-08-02
2018-06-300.881.070.1921 
2018-05-03
2018-03-310.22-0.03-0.25113 
2018-02-22
2017-12-310.70.740.04
2017-11-02
2017-09-300.410.730.3278 
2017-08-03
2017-06-300.260.13-0.1350 
2017-05-04
2017-03-310.30.29-0.01
2017-02-23
2016-12-310.480.740.2654 
2016-11-07
2016-09-300.260.580.32123 
2016-08-04
2016-06-30-0.17-0.18-0.01
2016-05-05
2016-03-31-0.070.160.23328 
2016-02-25
2015-12-310.70.780.0811 
2015-11-05
2015-09-300.550.830.2850 
2015-08-06
2015-06-300.180.360.18100 
2015-05-07
2015-03-31-0.44-0.5-0.0613 
2015-03-05
2014-12-310.690.750.06
2014-11-06
2014-09-300.520.540.02
2014-08-07
2014-06-300.320.25-0.0721 
2014-05-08
2014-03-31-0.14-0.48-0.34242 
2014-03-06
2013-12-310.360.410.0513 
2013-11-07
2013-09-300.210.360.1571 
2013-08-05
2013-06-300.210.290.0838 
2013-05-02
2013-03-31-0.14-0.22-0.0857 
2013-03-07
2012-12-310.450.44-0.01
2012-11-01
2012-09-300.140.180.0428 
2012-08-02
2012-06-300.230.21-0.02
2012-05-03
2012-03-31-0.15-0.020.1386 
2012-03-08
2011-12-310.720.780.06
2011-11-03
2011-09-300.10.04-0.0660 
2011-08-04
2011-06-300.340.390.0514 
2011-05-05
2011-03-31-0.52-0.61-0.0917 
2011-03-10
2010-12-310.670.760.0913 
2010-11-04
2010-09-300.520.41-0.1121 
2010-08-05
2010-06-300.260.310.0519 
2010-05-05
2010-03-310.170.08-0.0952 
2010-03-04
2009-12-310.050.130.08160 
2009-11-05
2009-09-300.060.03-0.0350 
2009-08-06
2009-06-300.30.480.1860 
2009-05-07
2009-03-310.130.350.22169 
2009-03-05
2008-12-310.020.050.03150 
2008-11-06
2008-09-300.180.340.1688 
2008-08-07
2008-06-300.230.06-0.1773 
2008-05-07
2008-03-310.270.24-0.0311 
2008-03-07
2007-12-310.870.930.06
2007-11-02
2007-09-30-0.030.10.13433 
2007-08-06
2007-06-30-0.25-0.170.0832 
2007-05-09
2007-03-310.02-0.1-0.12600 
2007-03-22
2006-12-310.791.030.2430 

About Emergent Biosolutions Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Emergent Biosolutions earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Emergent Biosolutions estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Emergent Biosolutions fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit957.8 MB
Earning Before Interest and Taxes EBIT348.9 M376.4 M
Earnings per Basic Share 4.32  4.66 
Earnings per Diluted Share 4.27  4.61 
Price to Earnings Ratio 10.06  10.33 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA472.7 M510 M
Earnings before Tax314.4 M339.2 M
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats in the United States. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland. Emergent Biosolutions operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 2416 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Emergent Biosolutions without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Pair Trading with Emergent Biosolutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.
The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Investing Opportunities. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.022
Market Capitalization
1.5 B
Quarterly Revenue Growth YOY
-0.39
Return On Assets
0.049
Return On Equity
0.0631
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.